PointState Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-47,235
| Closed | -$3.64M | – | 46 |
|
|
2022
Q2 | $3.64M | Buy |
+47,235
| New | +$3.64M | 0.09% | 44 |
|
|
2022
Q1 | – | Sell |
-77,500
| Closed | -$4.83M | – | 71 |
|
|
2021
Q4 | $4.83M | Buy |
+77,500
| New | +$4.83M | 0.08% | 65 |
|
|
2021
Q1 | – | Sell |
-76,828
| Closed | -$4.77M | – | 100 |
|
|
2020
Q4 | $4.77M | Buy |
+76,828
| New | +$4.77M | 0.09% | 79 |
|
|
2019
Q2 | – | Sell |
-2,244,489
| Closed | -$107M | – | 97 |
|
|
2019
Q1 | $107M | Buy |
+2,244,489
| New | +$107M | 2.11% | 14 |
|
|
2017
Q4 | – | Sell |
-20,000
| Closed | -$1.28M | – | 132 |
|
|
2017
Q3 | $1.28M | Sell |
20,000
-2,139,250
| -99% | -$136M | 0.01% | 127 |
|
|
2017
Q2 | $120M | Sell |
2,159,250
-480,050
| -18% | -$26.7M | 1.31% | 23 |
|
|
2017
Q1 | $144M | Buy |
2,639,300
+2,382,000
| +926% | +$130M | 1.5% | 19 |
|
|
2016
Q4 | $15M | Buy |
+257,300
| New | +$15M | 0.22% | 77 |
|